KIM LLC’s Ibere Pharmaceuticals IBER Stock Holding History

KIM LLC’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-450,000	Closed	-$4.54M	–	658
2022 Q4	$4.54M	Hold	450,000	–	–	0.25%	85
2022 Q3	$4.46M	Hold	450,000	–	–	0.21%	107
2022 Q2	$4.42M	Buy	+450,000	New	+$4.41M	0.21%	109

KIM LLC's IBER Position: Q1 2023 in Review

KIM LLC sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 450,000 shares — an estimated $4.54M sold.

KIM LLC first reported a position in IBER in Q2 2022 and held it in 3 quarters. The position peaked at $4.54M in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

KIM LLC reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
KIM LLC sold 450,000 Ibere Pharmaceuticals shares in Q1 2023, an estimated $4.54M.
KIM LLC first reported a position in Ibere Pharmaceuticals in Q2 2022 and held it in 3 quarters.
KIM LLC's Ibere Pharmaceuticals position peaked at $4.54M in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on KIM LLC's 13F filing for Q1 2023, filed 11 May 2023.